Evidence map›Paper›PMID 31934004›Full record

ArticleInternational journal of clinical and experimental pathology2019

Clinicopathologic and treatment features of aggressive angiomyxoma: a case report.

Chen Lin, Fei Huang, Fen Li, Xiaonan Zhu, Xiaojuan Jiang, Liping Tie, Guqun Shen, Jingxin Cheng

Open access · greenAbstract readCase Reports
In one paragraph

Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Aggressive angiomyxoma of the epididymis: A case report.World journal of clinical cases · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chen LinDepartment of Pathology, Basic Medical Sciences, Xinjiang Medical University No. 393 Xinyi Road, Urumqi 830011, China.
Fei HuangDepartment of Pathology, The Affiliated Tumor Hospital of Xinjiang Medical University No. 789 Suzhoudong Road, Urumqi 830000, China.
Fen LiThe Third Department of Gynecology, The Affiliated Tumor Hospital of Xinjiang Medical University No. 789 Suzhoudong Road, Urumqi 830000, China.
Xiaonan ZhuThe Third Department of Gynecology, The Affiliated Tumor Hospital of Xinjiang Medical University No. 789 Suzhoudong Road, Urumqi 830000, China.
Xiaojuan JiangThe Third Department of Gynecology, The Affiliated Tumor Hospital of Xinjiang Medical University No. 789 Suzhoudong Road, Urumqi 830000, China.
Liping TieThe Third Department of Gynecology, The Affiliated Tumor Hospital of Xinjiang Medical University No. 789 Suzhoudong Road, Urumqi 830000, China.
Guqun ShenThe Third Department of Gynecology, The Affiliated Tumor Hospital of Xinjiang Medical University No. 789 Suzhoudong Road, Urumqi 830000, China.
Jingxin ChengDepartment of Obstetrics and Gynecology, Shanghai East Hospital Affiliated to Tongji University No. 150 Jimo Road, Shanghai 200120, China.
Xinjiang Medical University · CNShanghai East Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe present study is to accumulate clinicopathologic and treatment data on aggressive angiomyxoma (AA), a rare tumor.

methodsVarious clinical findings were analyzed in 9 patients with AA at Affiliated Tumor Hospital of Xinjiang Medical University from 1996 to 2016.

resultsNine patients (8 females and 1 male) were included in the present study, with an age range from 14 to 63 years (median age, 33.4 years). The sites of tumor in 6 cases were perineum and vagina, right breast, left pelvic peritoneum and right groin (male). Gross examination showed that the tumor was solid and soft, with unclear boundary but no capsule. The cut surface was gray and jelly-like. According to microscopic examination, the tumor had invasive growth, and small fusiform or star-shaped cells being dispersed in a myxoid background, enclosing several capillary structures with a thin wall. The initial treatment was localized excision. Follow-up showed that 2 patients died from cardiovascular and cerebrovascular disease, 2 patients had local recurrence, 2 patients were withdrawn, and others had neither local recurrence nor distant metastasis. Follow-up time was 3-25 years.

conclusionAA is a rare tumor that occurs predominantly in females. Local resection is appropriate to manipulate the tumor, and local recurrence is common.

Indexed as

Aggressive angiomyxomapathologic analysissurgical treatment

Identifiers

PMID31934004
PMCPMC6947119
OpenAlexW3006167074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.